Clinical Trial Update: Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lifileucel plus pembrolizumab versus pembrolizumab alone in untreated advanced melanoma (metastatic/unresectable); recruitment is ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Unresectable Melanoma

Drugs mentioned

• Lifileucel (autologous tumor-infiltrating lymphocytes (TIL) therapy)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Iovance Biotherapeutics, Inc. | Conditions: Metastatic Melanoma, Unresectable Melanoma | Phase 3 | Status: RECRUITING